Therefore, targeting UBR5 or UBR5-mediated CAPZA1 ubiquitination will provide promising strategies for preventing cancer metastasis in pancreatic cancer patients, particularly in those with high UBR5 expression. Here, CAPZA1 is linked to cancer.